Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report

Parham Habibzadeh, Anushri Kulkarni, Drew Hurd, Amy Rose, Danielle Bednarz, Yana G. Najjar, John M. Kirkwood, Arivarasan Karunamurthy, Diwakar Davar

Open source

DOI
10.3389/fimmu.2026.1864115
Published
2026-07-02
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1864115,
  title = {Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report},
  author = {Parham Habibzadeh and Anushri Kulkarni and Drew Hurd and Amy Rose and Danielle Bednarz and Yana G. Najjar and John M. Kirkwood and Arivarasan Karunamurthy and Diwakar Davar},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1864115},
  url = {https://doi.org/10.3389/fimmu.2026.1864115}
}

RIS

TY  - JOUR
TI  - Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report
AU  - Parham Habibzadeh
AU  - Anushri Kulkarni
AU  - Drew Hurd
AU  - Amy Rose
AU  - Danielle Bednarz
AU  - Yana G. Najjar
AU  - John M. Kirkwood
AU  - Arivarasan Karunamurthy
AU  - Diwakar Davar
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1864115
UR  - https://doi.org/10.3389/fimmu.2026.1864115
ER  - 

APA

Habibzadeh, P., Kulkarni, A., Hurd, D., Rose, A., Bednarz, D., Najjar, Y. G., Kirkwood, J. M., Karunamurthy, A., & Davar, D. (2026). Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1864115

Source records